PMID- 30107664 OWN - NLM STAT- MEDLINE DCOM- 20181003 LR - 20190318 IS - 0529-5807 (Print) IS - 0529-5807 (Linking) VI - 47 IP - 8 DP - 2018 Aug 8 TI - [Relationship between PD-L1 protein expression and gene amplification in gastric cancer tissues]. PG - 597-602 LID - 10.3760/cma.j.issn.0529-5807.2018.08.006 [doi] AB - Objective: To investigate the relationship of PD-L1 protein expression and gene amplification in gastric cancer and their correlation with clinicopathologic factors. Methods: The cohort included 247 gastric cancer specimens with follow-up data and clinicopathologic data obtained from Shanxi Cancer Hospital in 2011. PD-L1 expression was detected by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Results: PD-L1 protein was expressed in 25.9% (64/247) of the tumor cells and 26.7% (66/247) of the tumor infiltrating immune cells (IC). There was a correlation between the two (P<0.01). The expression of PD-L1 in tumor cells correlated with the degree of differentiation and tumor diameter(P<0.05). The PD-L1 expression in IC correlated with vascular tumor thrombi(P<0.05). The amplification rate of PD-L1 gene detected by FISH was 19.0% (47/247), and was associated with age, large/small curvature of the stomach, tumor location, tumor diameter, and lymph node metastasis(P<0.05). The positive coincidence rate of the two methods was 25.0% (16/64), negative coincidence rate was 83.0% (152/183), and total coincidence rate was 68.0% (168/247), suggesting that the coincidence of IHC and FISH was poor (P=0.157). There was a negative correlation between PD-L1 protein expression on tumor cells and prognosis in gastric cancer. There was no significant correlation between PD-L1 protein expression on IC and PD-L1 gene amplification with prognosis. Vascular tumor thrombi, tumor diameter, depth of invasion, and lymph node metastasis were all poor prognostic factors of gastric cancer(P<0.05). Multivariate Cox regression analysis showed that PD-L1 protein expression, depth of invasion and lymph node metastasis were all independent prognostic risk factors for gastric cancer. Conclusions: Concordance between PD-L1 protein expression and gene amplification is poor. PD-L1 protein expression may signify poor prognosis. There is no significant correlation between PD-L1 gene amplification and prognosis of patients with gastric cancer. FAU - Liu, Y AU - Liu Y AD - Department of Pathology, Shanxi Medical University, Taiyuan 030001, China. FAU - Wang, J F AU - Wang JF FAU - Li, X W AU - Li XW FAU - Bu, P AU - Bu P FAU - Bai, W AU - Bai W FAU - Li, L M AU - Li LM LA - chi PT - Journal Article PL - China TA - Zhonghua Bing Li Xue Za Zhi JT - Zhonghua bing li xue za zhi = Chinese journal of pathology JID - 0005331 RN - 0 (Antigens, Neoplasm) RN - 0 (B7-H1 Antigen) RN - 0 (CD274 protein, human) SB - IM MH - Antigens, Neoplasm/*metabolism MH - B7-H1 Antigen/*metabolism MH - *Gene Amplification MH - Humans MH - Immunohistochemistry MH - In Situ Hybridization, Fluorescence MH - Lymphatic Metastasis MH - Lymphocytes, Tumor-Infiltrating/*metabolism MH - Prognosis MH - Proteomics MH - Risk Factors MH - Stomach Neoplasms/*genetics/*metabolism/pathology MH - Tumor Burden OTO - NOTNLM OT - Gene amplification OT - Prognosis OT - Programmed death-ligand 1(PD-L1) OT - Stomach neoplasms EDAT- 2018/08/16 06:00 MHDA- 2018/10/04 06:00 CRDT- 2018/08/15 06:00 PHST- 2018/08/15 06:00 [entrez] PHST- 2018/08/16 06:00 [pubmed] PHST- 2018/10/04 06:00 [medline] AID - 10.3760/cma.j.issn.0529-5807.2018.08.006 [doi] PST - ppublish SO - Zhonghua Bing Li Xue Za Zhi. 2018 Aug 8;47(8):597-602. doi: 10.3760/cma.j.issn.0529-5807.2018.08.006.